AQST
AQST
US03843E1047
Aquestive Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 44.545.000 57.561.000
22.6%
Cost of Revenue 18.555.000 17.872.000
3.8%
Gross Profit 25.990.000 39.689.000
34.5%
97.041.000 70.460.000
37.7%
Operating Income -71.051.000 -30.771.000
130.9%
Pretax Income -83.784.000 -44.151.000
89.8%
Net Income Common Stockholders -83.784.000 -44.137.000
89.8%
-- --
--
-- --
--
ende